ethyl lauroyl arginate
Small moleculeexperimental
Ethyl lauroyl arginate (LAE) is a food preservative, antimicrobial compound, and drug more commonly known as E243. It is used to treat dermatological disorders and is often provided in the form of its hydrochloride salt. LAE is an amino acid-based surfactant with broad-spectrum antimicrobial activity, high biodegradability and low toxicity. Due to these features, LAE is a preservative used in food and cosmetic formulations. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Sep 1, 2015 (NCT02884817)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Cell membraneDEGRADER
Cell membrane degrader
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaEthyl lauroyl arginate ↗
Also known as
- ethyl lauroyl arginate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02884817 | Phase 4 | Sep 1, 2015 | University of Oslo |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oslo | Academic/Hospital | 1 | 1 | 1 | 2015 |
1 organizations
Page 1 / 1